Letter to the Editor

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4448-4450
DOI: 10.26355/eurrev_202107_26234

2-Deoxy-D-glucose: is this the final cure for COVID-19: or yet another mirage?

S. Halder, A.K. Mehta
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4446-4447
DOI: 10.26355/eurrev_202107_26233

Letter to editor on the paper entitled “Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19”

O. Nugraha Putra
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4443-4444
DOI: 10.26355/eurrev_202107_26231

COVID-19 in a child with Still’s disease (systemic juvenile idiopathic arthritis): 9th case described

J. Freire de Carvalho
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4441-4442
DOI: 10.26355/eurrev_202107_26230

Treatment options after regorafenib failure in metastatic colorectal cancer

M. Berretta, F. Fiorica, V. Quagliariello, M.M. Laterza, G. Facchini, M. Montopoli
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (12): 4186-4187
DOI: 10.26355/eurrev_202106_26119

Paget’s disease of the breast: strategy to improve oncological and aesthetic results

G. Franceschini, R. Masetti
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (11): 3936-3937
DOI: 10.26355/eurrev_202106_26033

The establishment of the Experts Group on Inositol in Basic and Clinical Research (EGOI), a scientific association of the foremost experts on Inositol applications

V. Unfer, F. Facchinetti
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (11): 3934-3935
DOI: 10.26355/eurrev_202106_26032

Relapsing polychondritis following silicone breast implant: first description

J.F. de Carvalho
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (10): 3645-3646
DOI: 10.26355/eurrev_202105_25929

Prevalence of genetic thrombophilia in primary antiphospholipid syndrome

N.S.R. Neto, C.C. Strunz, J.F. de Carvalho
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (9): 3401-3402
DOI: 10.26355/eurrev_202105_25816

SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy

M. Candelli, G. Pignataro
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (8): 3153-3153
DOI: 10.26355/eurrev_202104_25723

Comment on “Circ_0009910 promotes proliferation and metastasis of hepatocellular carcinoma cells through miR-335-5p/ROCK1 axis”

J. Lin
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (7): 2830-2833
DOI: 10.26355/eurrev_202104_25535

Comment on the article by Zaami S, et al. “CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19”. Eur Rev Med Pharmacol Sci 2021; 25 (3): 1752-1761

A. Del Rio, F. Negro, F. Umani Ronchi
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2478-2480
DOI: 10.26355/eurrev_202103_25410

Polyautoimmunity (Psoriasis, Sjogren’s syndrome, and autoimmune uveitis) following polymethylmethacrylate injection

J. Freire de Carvalho
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2475-2477
DOI: 10.26355/eurrev_202103_25409

Antifungal cerebrospinal levels and susceptibility profile in cryptococcal meningitis in the context of intracranial hypertension

F. Wirth, D. Príscila, P. Rosa, A. Valério, L.Z. Goldani
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2473-2474
DOI: 10.26355/eurrev_202103_25408

Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis

M. Ceccarelli, P. Pavone, E. Venanzi Rullo, G. Nunnari
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2470-2472
DOI: 10.26355/eurrev_202103_25407

Ozone therapy may be an option for COVID-19 patients

M. Şahin, F. Eryilmaz, H.H. Keser Şahin
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2468-2469
DOI: 10.26355/eurrev_202103_25406

Leading cause of death in comparison to COVID-19 in Saudi Arabia

S. Bashir, N. Altwaijri, T.M. Al-Harbi, T. Abualait
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2464-2467
DOI: 10.26355/eurrev_202103_25391

Transparency of disinfectant and hand sanitizer contents in the context of COVID-19

N. Cimolai
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2166-2167
DOI: 10.26355/eurrev_202103_25205

Hyperlipidemia management during the COVID-19 pandemic: PCSK9 inhibitors to enhance the antiviral action of interferon

M. Leggio, A. Villano, A. Fusco, A. Mazza
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2163-2165
DOI: 10.26355/eurrev_202103_25204

Our mind-body reactions to COVID-19

S. Bashir, M. Asim, E. Nasim
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 1770-1771
DOI: 10.26355/eurrev_202102_25067

Diagnosing SARS-CoV-2 associated myositis should not rely on the profile of myositis-specific antibodies alone

J. Finsterer
Free PDF Download